Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESGO 2021 | Gestational trophoblastic tumors

Benoit You • 28 Oct 2021
ESGO 2021
Gynecological Cancer

Benoit You, MD, PhD, Centre Hospitalier Lyon-Sud, Saint-Genis-Laval, France, gives an overview of gestational trophoblastic tumors, including their incidence and early symptoms. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

Disclosures

Prof. You reports consulting for MSD, Astra-Zeneca, GSK-TESARO, BAYER, Roche-Genentech, ECS Progastrine, Novartis, LEK, Amgen, Clovis Oncology, Merck Serono, BMS, SEAGEN, Myriad.

More from Benoit You

1:01
ESMO 2023 highlights in the treatment of ovarian cancer
Benoit You • 23 Oct 2023
1:15
The influence of HRD testing in precision medicine
Benoit You • 23 Oct 2023
1:37
Updates in ICIs and ADCs in cervical cancer
Benoit You • 23 Oct 2023
1:21
Evaluating the interchangeability of HRD testing in ovarian cancer
Benoit You • 23 Oct 2023

Related Videos

0:39
Early diagnosis of ovarian cancer with Pap smears
Sergio Marchini • 8 Apr 2024
0:46
FRa expression and sequencing ADCs in endometrial cancer
Rebecca Porter • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:11
Clonal hematopoiesis mutations in ovarian carcinomas
Rebecca Porter • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals